Opendata, web and dolomites

BQ-Technology

BrainQ, non-invasive, very low intensity, BCI-based frequency dependent electromagnetic field tailored treatment for neuro recovery (BQ).

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BQ-Technology project word cloud

Explore the words cloud of the BQ-Technology project. It provides you a very rough idea of what is the project "BQ-Technology" about.

scalable    doubles    linked    aging    device    infections    rehabilitation    clinical    triggers    risk    neurological    indication    regain    globally    eeg    skills    treatment    decade    remarkable    frequencies    treat    artificial    algorithms    operated    injuries    frequency    materials    patterns    sensorimotor    causes    translated    impairments    dementia    cloud    easily    healthcare    first    disorders    patients    living    network    global    bq    recovery    spectral    stimulation    care    motor    attributable    decreased    functional    human    brainq    populations    bill    strokes    connected    age    interface    variety    uses    perform    back    intelligence    patient    operator    neuro    sensor    electromagnetic    computer    paralysed    55    efficacy    revolutionary    anomalous    cognitive    agnostic    burden    time    deficits    prevalence    death    neural    disability    restore    animal    impaired    feet    invasive    brain    viral    trials    world    mortality    designed    dependent    daily    continue    natural    demonstrated    stroke    proprietary    waves   

Project "BQ-Technology" data sheet

The following table provides information about the project.

Coordinator
BRAINQ TECHNOLOGIES LTD 

Organization address
address: 4/4 HIGH TECH VILLAGE GIVAT RAM
city: JERUSALEM
postcode: 39129
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://brainqtech.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BRAINQ TECHNOLOGIES LTD IL (JERUSALEM) coordinator 50˙000.00

Map

 Project objective

The WHO has identified neurological disorders as a major burden and emerging challenge to global healthcare systems. These range from causes such as stroke and dementia, to injuries and viral infections. The prevalence of strokes and dementia are strongly linked to increasing age, for example stroke risk more than doubles every decade after 55 . Although, mortality attributable to stroke has decreased over time Stroke remains a leading cause of death and disability globally and can cause significant deficits in sensorimotor skills and cognitive abilities.

With the increasingly aging populations across the world and particularly in Europe, the burden of care from Neurological disorders is set to continue increasing.

BrainQ’s BQ system is a revolutionary Brain Computer Interface-based stimulation device used to enhance neuro-recovery. Our device uses proprietary, artificial intelligence algorithms to identify anomalous spectral patterns in patient's brain waves (“EEG”). These patterns are then translated into a tailored frequency dependent electromagnetic treatment targeting specific impaired functional neural network associated with these frequencies and triggers natural rehabilitation thus promoting neuro recovery process.

Device is designed to enable non-invasive treatment for motor impairments following a variety of neurological disorders; help patients get back on their feet and restore their ability to perform activities of daily living. Treatment is tailored to each patient, is patient friendly, non-invasive, cloud connected & scalable, with low Bill of Materials, and operator & indication agnostic. This means it is easily operated and can be used to treat a variety of neurological disorders. Pre-clinical animal trials and first-in-human clinical trials have demonstrated remarkable efficacy, allowing paralysed patients regain sensor and motor abilities.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BQ-TECHNOLOGY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BQ-TECHNOLOGY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More